BALAXI2023-04-012023-06-30 BALAXI2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member BALAXI2023-06-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares BALAXI NOTLISTED BALAXI PHARMACEUTICALS LIMITED Equity 2023-04-01 2024-03-31 2023-08-03 2023-07-27 INR Lakhs First quarter 10:30:00 14:15:00 2023-08-03 2023-08-03 Not applicable Single segment Specialized Wholesale 2023-04-01 2023-06-30 Unaudited Standalone 250403000.00 1258000.00 251661000.00 191442000.00 0.00 0.00 12361000.00 2579000.00 1305000.00 8890000.00 216577000.00 35084000.00 0.00 35084000.00 9573000.00 -31000.00 9542000.00 0.00 25542000.00 0.00 0.00 0.00 0.00 25542000.00 0.00 25542000.00 25542000.00 0.00 102302000.00 10 2.50 2.47 0.00 0.00 2.50 2.47 1. The Unaudited Standalone Financial Results for the Quarter ended June 30, 2023 have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on August 03, 2023. The Standalone Financial Results are prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013. 2. Previous period figures have been regrouped, re-arranged and re-classified wherever necessary to conform to current period’s classification. 3. The operating segment of the Group is identified as Specialized Wholesale as the Chief Operating Decision Maker reviews business performance at an overall level as one segment. Therefore, the disclosure as per Regulation 33 (1)(e ) read with Clause L of Schedule IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable to the Company. Administrative Expenses 8890000.00 0.00 0.00